Cargando…

Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009

PURPOSE: The increasing prevalence of antimicrobial resistant bacteria has become a serious worldwide problem. The aim of this study was to analyze antimicrobial resistance data generated in 2009 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of Antimicr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyungwon, Kim, Mi-Na, Kim, Jae-Seok, Hong, Hye Lim, Kang, Jung Oak, Shin, Jong Hee, Park, Yeon-Joon, Yong, Dongeun, Jeong, Seok Hoon, Chong, Yunsop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159946/
https://www.ncbi.nlm.nih.gov/pubmed/21786445
http://dx.doi.org/10.3349/ymj.2011.52.5.793
_version_ 1782210498917302272
author Lee, Kyungwon
Kim, Mi-Na
Kim, Jae-Seok
Hong, Hye Lim
Kang, Jung Oak
Shin, Jong Hee
Park, Yeon-Joon
Yong, Dongeun
Jeong, Seok Hoon
Chong, Yunsop
author_facet Lee, Kyungwon
Kim, Mi-Na
Kim, Jae-Seok
Hong, Hye Lim
Kang, Jung Oak
Shin, Jong Hee
Park, Yeon-Joon
Yong, Dongeun
Jeong, Seok Hoon
Chong, Yunsop
author_sort Lee, Kyungwon
collection PubMed
description PURPOSE: The increasing prevalence of antimicrobial resistant bacteria has become a serious worldwide problem. The aim of this study was to analyze antimicrobial resistance data generated in 2009 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of Antimicrobial Resistance program. MATERIALS AND METHODS: Susceptibility data were collected from 24 hospitals and two commercial laboratories. In the analysis, resistance did not include intermediate susceptibility. Duplicate isolates were excluded from the analysis of hospital isolates, but not from the commercial laboratory isolates. RESULTS: Among the hospital isolates, methicillin-resistant Staphylococcus aureus, penicillin G-non-susceptible Streptococcus pneumoniae based on meningitis breakpoint, and ampicillin-resistant Enterococcus faecium remained highly prevalent. The proportion of vancomycin-resistant E. faecium gradually increased to 29%. Ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae increased to 17% and 33%, respectively, and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp. and Pseudomonas aeruginosa increased to 33%, 67% and 39%, respectively. Amikacin-resistant Acinetobacter spp. increased to 48%. Imipenem-resistant Acinetobacter spp. and P. aeruginosa increased to 51% and 26%, respectively. Higher resistance rates were observed in intensive care unit (ICU) isolates than in non-ICU isolates among the isolates from hospitals. Resistance rates were higher in hospital isolates than in clinic isolates among the isolates from commercial laboratories. CONCLUSION: Among the hospital isolates, ceftazidime-resistant K. pneumoniae and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp., and P. aeruginosa further increased. The increase in imipenem resistance was slight in P. aeruginosa, but drastic in Acinetobacter spp. The problematic antimicrobial-organism combinations were much more prevalent among ICU isolates.
format Online
Article
Text
id pubmed-3159946
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-31599462011-09-07 Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009 Lee, Kyungwon Kim, Mi-Na Kim, Jae-Seok Hong, Hye Lim Kang, Jung Oak Shin, Jong Hee Park, Yeon-Joon Yong, Dongeun Jeong, Seok Hoon Chong, Yunsop Yonsei Med J Original Article PURPOSE: The increasing prevalence of antimicrobial resistant bacteria has become a serious worldwide problem. The aim of this study was to analyze antimicrobial resistance data generated in 2009 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of Antimicrobial Resistance program. MATERIALS AND METHODS: Susceptibility data were collected from 24 hospitals and two commercial laboratories. In the analysis, resistance did not include intermediate susceptibility. Duplicate isolates were excluded from the analysis of hospital isolates, but not from the commercial laboratory isolates. RESULTS: Among the hospital isolates, methicillin-resistant Staphylococcus aureus, penicillin G-non-susceptible Streptococcus pneumoniae based on meningitis breakpoint, and ampicillin-resistant Enterococcus faecium remained highly prevalent. The proportion of vancomycin-resistant E. faecium gradually increased to 29%. Ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae increased to 17% and 33%, respectively, and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp. and Pseudomonas aeruginosa increased to 33%, 67% and 39%, respectively. Amikacin-resistant Acinetobacter spp. increased to 48%. Imipenem-resistant Acinetobacter spp. and P. aeruginosa increased to 51% and 26%, respectively. Higher resistance rates were observed in intensive care unit (ICU) isolates than in non-ICU isolates among the isolates from hospitals. Resistance rates were higher in hospital isolates than in clinic isolates among the isolates from commercial laboratories. CONCLUSION: Among the hospital isolates, ceftazidime-resistant K. pneumoniae and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp., and P. aeruginosa further increased. The increase in imipenem resistance was slight in P. aeruginosa, but drastic in Acinetobacter spp. The problematic antimicrobial-organism combinations were much more prevalent among ICU isolates. Yonsei University College of Medicine 2011-09-01 2011-07-18 /pmc/articles/PMC3159946/ /pubmed/21786445 http://dx.doi.org/10.3349/ymj.2011.52.5.793 Text en © Copyright: Yonsei University College of Medicine 2011 http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Kyungwon
Kim, Mi-Na
Kim, Jae-Seok
Hong, Hye Lim
Kang, Jung Oak
Shin, Jong Hee
Park, Yeon-Joon
Yong, Dongeun
Jeong, Seok Hoon
Chong, Yunsop
Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
title Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
title_full Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
title_fullStr Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
title_full_unstemmed Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
title_short Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
title_sort further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of acinetobacter spp. and p. aeruginosa in korea: konsar study 2009
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159946/
https://www.ncbi.nlm.nih.gov/pubmed/21786445
http://dx.doi.org/10.3349/ymj.2011.52.5.793
work_keys_str_mv AT leekyungwon furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT kimmina furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT kimjaeseok furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT honghyelim furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT kangjungoak furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT shinjonghee furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT parkyeonjoon furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT yongdongeun furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT jeongseokhoon furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT chongyunsop furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009
AT furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009